« Back
Home /
Xylazine-BSA Conjugate - 1 mg

Xylazine-BSA Conjugate - 1 mg

Item no.	LEIN-X123-1mg
Manufacturer	Leinco Technologies
Amount	1 mg
Category	Peptides & Proteins ELISA Peptides Immunostaining Lateral Flow
Type	Proteins Synthetic
Applications	ELISA, LF
Specific against	other
ECLASS 10.1	32160409
ECLASS 11.0	32160409
UNSPSC	12352202
Shipping Condition	Cool pack
Available
Manufacturer - Category	Hapten/Conjugate\|Recombinant Proteins
Shipping Temperature	2 - 8°C Wet Ice
Storage Conditions	This product is stable when stored at 2-8°C. Do not freeze.
Product Description	Xylazine is a potent alpha-2 adrenergic agonist that was initially developed as a veterinary sedative and analgesic medication. Xylazine was not approved for human use and has been increasingly found in samples of illicit drugs like fentanyl. The increase in the detection of xylazine mixed with fentanyl has corresponded with an increase in overdose deaths. In 2023, fentanyl mixed with xylazine was declared an emerging threat by the White House’s Office of National Drug Control Policy.
Manufacturer - Research Area	Drug of Abuse, Matched Pair, Antigen, IVD Raw Material
Concentration	5.0 mg/mL
Formulation	Formulated in 0.015 M phosphate buffered saline (0.15M NaCl) and contains 0.05% sodium azide.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: 1 mg

available

Delivery expected until 10/9/2025

Express Delivery: Save 2 days

Compare

Add to wishlist

Get an offer